<- Go Home
Venus Remedies Limited
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.
Market Cap
INR 10.5B
Volume
5.2K
Cash and Equivalents
N/A
EBITDA
INR 1.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
INR 3.3B
Profit Margin
46.72%
52 Week High
INR 848.90
52 Week Low
INR 277.85
Dividend
N/A
Price / Book Value
1.76
Price / Earnings
13.75
Price / Tangible Book Value
2.12
Enterprise Value
INR 8.3B
Enterprise Value / EBITDA
7.80
Operating Income
INR 916.6M
Return on Equity
N/A
Return on Assets
N/A
Cash and Short Term Investments
N/A
Debt
N/A
Equity
N/A
Revenue
INR 7.0B
Unlevered FCF
N/A
Sector
Pharmaceuticals
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium